Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. QGEN
10. SPY

Go back to Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance

Charles River Laboratories (CRL) shares plunge after Justice Department subpoena relating to NHPs

February 22, 2023 12:16 PM EST

Charles River Laboratories (NYSE: CRL) shares plummeted over 14% Wednesday after the company said in its latest earnings report that it has received a subpoena from the U.S. Department of Justice in connection with an investigation into the Cambodian non-human primate (NHP) supply... More

Charles River Laboratories (CRL) Tops Q4 EPS by 23c; Guides FY23 EPS Below Views

February 22, 2023 7:06 AM EST

Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $2.98, $0.23 better than the analyst estimate of $2.75. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.04 billion.

GUIDANCE:

Charles River Laboratories sees FY2023 EPS of $9.70-$10.90. Charles River... More